Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
149 participants
INTERVENTIONAL
2008-06-16
2023-05-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552
Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women
NCT03789513
Characterization of Immunosuppressive Signing of Cervical Cancer
NCT02875990
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01014026
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NCT04901351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Is correlated to the transcription of the genes of the oncoproteins E6 and E7
* Is predictive of the integration of the virus in infected cells
* Is predictive of the presence of HPV in patients' blood
* Influences the local and systemic immunologic response
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
125 womens with normal cervix
2 cervical takings and 2 sampling of blood
* 2 cervical takings
* 2 sampling of blood before and after the total hysterectomy
2
105 womens with an intraepithelial lesion
2 cervical takings and 2 sampling of blood
* cervical taking during the cervical conization
* 2 sampling of blood before and after the intervention
3
105 womens with a cancer of the cervix
2 cervical takings and 2 sampling of blood
* cervical taking during the pelvien examination under general anesthetic realized systematically during the balance sheet of pre-therapeutic evaluation
* 2 sampling of blood before and after the intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2 cervical takings and 2 sampling of blood
* 2 cervical takings
* 2 sampling of blood before and after the total hysterectomy
2 cervical takings and 2 sampling of blood
* cervical taking during the cervical conization
* 2 sampling of blood before and after the intervention
2 cervical takings and 2 sampling of blood
* cervical taking during the pelvien examination under general anesthetic realized systematically during the balance sheet of pre-therapeutic evaluation
* 2 sampling of blood before and after the intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The women having a normal cervix consulting for the surgical care by hysterectomy of a good-hearted pathology of the womb. The normality of the cervix will be confirmed by the anatomopathologique analysis of the detail of hysterectomy
* The patients participating in this study will have to be of more than 18 years old. All the subjects will be profitable of a regime of Social Security.
Exclusion Criteria
* The patients incapable to receive the information enlightened on the progress and the objectives of the study
* The patients not having signed enlightened assent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier CARCOPINO, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hopitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Nord, service de gynécologie-obstétrique
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-30
Identifier Type: -
Identifier Source: secondary_id
2007-A01335-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.